carbamates has been researched along with DDD MPGNII in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Shimada, M | 1 |
Nakamura, N | 1 |
Endo, T | 1 |
Yamabe, H | 1 |
Nakamura, M | 1 |
Murakami, R | 1 |
Narita, I | 1 |
Tomita, H | 1 |
Elmowafy, AY | 1 |
El Maghrabi, HM | 1 |
Zahab, MA | 1 |
Elwasif, SM | 1 |
Bakr, MA | 1 |
1 review available for carbamates and DDD MPGNII
Article | Year |
---|---|
Daclatasvir/asunaprevir based direct-acting antiviral therapy ameliorate hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis: a case report.
Topics: Aged; Antiviral Agents; Carbamates; Cryoglobulinemia; Female; Glomerulonephritis, Membranoproliferat | 2017 |
1 other study available for carbamates and DDD MPGNII
Article | Year |
---|---|
Sofosbuvir and Daclatsvir in Treatment of Hepatitis C Virus-related Membranoproliferative Glomerulonephritis With Cryoglobulinemia in a Patient With Hepatitis C Genotype 4.
Topics: Antiviral Agents; Carbamates; Cryoglobulinemia; Drug Therapy, Combination; Female; Glomerulonephriti | 2018 |